Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections

Dalbavancin represents a promising treatment for cardiovascular prosthetic infections due to its prolonged half-life, bactericidal activity, large spectrum of activity, and excellent biofilm penetration. However, the use of dalbavancin in this setting is limited, and only a few cases have performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallerani, Altea, Gatti, Milo, Bedini, Andrea, Casolari, Stefania, Orlando, Gabriella, Puzzolante, Cinzia, Franceschini, Erica, Menozzi, Marianna, Santoro, Antonella, Barp, Nicole, Volpi, Sara, Soffritti, Alessandra, Pea, Federico, Mussini, Cristina, Meschiari, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669433/
https://www.ncbi.nlm.nih.gov/pubmed/37998841
http://dx.doi.org/10.3390/antibiotics12111639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669433/
https://www.ncbi.nlm.nih.gov/pubmed/37998841
http://dx.doi.org/10.3390/antibiotics12111639

Ejemplares similares